aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
From TechCrunch
By Marina Temkin
June 6, 2024
Over half of Americans wear corrective glasses or contact lenses. While there isn’t a shortage of low-cost and luxury frames available online or in stores, consumers can only buy them with a current eyeglass prescription.
That means that they first need an eye exam from an optometrist to receive that prescription. But, due to a nationwide shortage of eye care practitioners, it may take weeks, especially in rural areas, to get an appointment.
Eyebot, a new startup coming out of stealth on Thursday, wants to reduce the time it takes to receive an eye exam to about 90 seconds without the direct involvement of an optometrist. Starting in October, the Boston-based company will roll out its self-serv, vision-testing terminals in shopping centers, grocery stores and pharmacies in New England.
Anyone who wants to have their vision checked can walk up to Eyebot’s 5-ish-foot kiosk, press a button, and the company’s computer vision technology will automatically scan the person’s eyes, extracting eyeglass or contact lens prescription. (While Eyebot can’t perform initial fittings of contact lenses, it can update an existing prescription.)
Eyebot’s founder and CEO Matthias Hofmann said he developed similar technology ten years ago at EyeNetra, a startup that used smartphones to test eyesight. (EyeNetra went out of business several years ago, according to Hoffman, who worked there as the leading engineer until 2015.)
“We realized that using smartphones is not actually the solution,” said Hoffman, who, before joining EyeNetra, was a postdoctoral researcher in tomography at Harvard Medical School. “What people want is a fully automated experience where they don’t have to learn or do anything complicated. Our technology now allows people to simply stand in front of our units.”
Eyebot-generated prescriptions are finalized by teledoctors within 24 hours, and consumers who want to purchase glasses from any retailer must pay $30 for their exam. But if they purchase glasses from one of Eyebot’s partner brands, the eye exam is free. (The technology is registered with the FDA, Hoffman said.)
The company hopes that major eyeglass brands will rent Eyebot terminals and put them in the retail locations of their choice. Once a shopper finalizes their exam, they can choose to buy eyeglasses from that brand directly on a touchscreen within the kiosk or by using their smartphone. Eyebot plans to make money by partnering with these eyewear brands and taking a commission on each sale.
“Retailers are looking for new channels to reach the customers,” Hoffman said. “Now they have an opportunity to show their brand in CVS, Walgreens, Stop and Shop, Kroger and on college campuses.”
Eyebot is close to finalizing partnership agreements with several large eyeglass and contact lens merchants, Hoffman said. “It’s a very lucrative model. The demand for what we’re doing is very high.”
Demand for investing in Eyebot’s seed round was high, too, according to Hoffman. On Thursday, the company announced a $6 million funding round led by AlleyCorpand Ubiquity Ventures with participation from Susa Ventures, Village Global, Baukunst, Ravelin, and Spacecadet.
The capital will be used for expansion to geographies.
Share:
5 ways TechCrunch Sessions: AI will fuel your AI growth
Less than three months until TechCrunch’s biggest AI event yet! If you’re shaping the future of AI, investing in the next game-changing innovation, or simply eager to dive deep into what’s next, TechCrunch Sessions: AI is the place to be. On June 5, Zellerbach Hall in UC Berkeley, will be buzzing with 1,200 AI experts, investors, and enthusiasts exchanging ideas, forging connections, and exploring the frontier of artificial intelligence. Secure your spot now and save up to $210 before ticket pr
Mar 13, 2025
TechCrunch All Stage unveils a powerhouse agenda for founders
TechCrunch All Stage (formerly Early Stage) returns to Boston on July 15, and the agenda for our tentpole East Coast founder event is almost complete. We’re excited to share this sneak peek at some of the fantastic speakers and sessions we have on tap. For builders who are just starting on their founder journey, our Foundation Stage is absolutely the place to be. We’re enlisting a stellar cast of leading investors and entrepreneurs to dig deep into founder-focused topics such as: All the Ways
Mar 13, 2025
Omni raises $69M to design tools that help companies better analyze their data
Employees at many companies today are expected to make decisions through careful data analysis, but the tools they need to do it are clunky, slow or — in some cases — don’t exist. That’s according to Colin Zima, the CEO of Omni, a business intelligence (BI) platform that aims to help organizations simplify how they work with their data. Before co-founding Omni, Zima led the Search quality team at Google and was the chief analytics officer at Looker. “With cloud data warehouses like Snowflake an
Mar 13, 2025
Don't miss our latest news and updates. Subscribe to the newsletter